CANTISENSE
LIVE

Serial Number

90010716

Owner

Digital Diagnostics AG

Attorney

Leo M. Loughlin

Filing Date

Jun 19, 2020

Add to watchlist:

No watchlists yet
View on USPTO

CANTISENSE Trademark

Serial Number: 90010716 • Registration: 6600045

CANTISENSE is a trademark filed by Digital Diagnostics AG on June 19, 2020. The trademark is classified under Class 9 (Computers & Electronics), Class 10 (Medical Apparatus). The application is currently registered and active.

Owner Contact Info

Digital Diagnostics AG (3 trademarks)

Mainz 55129 , DE

Entity Type: 03

Trademark Details

Filing Date

June 19, 2020

Registration Date

December 28, 2021

Published for Opposition

October 12, 2021

Goods & Services

Recorded health monitoring software; downloadable health monitoring software; information technology, audio-visual, and multimedia devices, namely, portable digital devices in the nature of smartphones, smartwatches, tablets, and wearables, for recording, displaying, receiving health and lifestyle related text, data and files, and featuring sensors for scientific use to be worn by a human or animal to gather biometric data; measuring, detecting, monitoring and controlling devices for the diagnosis of viruses, bacteria, DNA fragments, RNA fragments, proteins and other substances in fluids or another sample collected from a human or an animal body, all for scientific or laboratory use, not for medical use; recorded content, namely, captured digital health data parameters, using biomarkers such as lactate, glucose, and various viruses, bacteria, and protein and other substances in fluids or another sample collected from a human or an animal body; diagnostic apparatus, not for medical purposes, for testing for viruses, bacteria, DNA fragments, RNA fragments, proteins and other substances in fluids or another sample collected from a human or an animal body; instruments for diagnosis for scientific use, namely, for detecting antigens or other specific binding partners of bacterial or virion particles, for determining the presence or absence of specific DNA or RNA segments, oligonucleotides, or proteins and other substances in fluids or another sample collected from a human or an animal body; scientific apparatus and instruments, namely, for detecting antigens or other specific binding partners of bacterial or virion particles, for determining the presence or absence of specific DNA or RNA segments, oligonucleotides, or proteins and other substances in fluids or another sample collected from a human or an animal body; laboratory apparatus and instruments, namely, for detecting antigens or other specific binding partners of bacterial or virion particles, for determining the presence or absence of specific DNA or RNA segments, oligonucleotides, or proteins and other substances in fluids or another sample collected from a human or an animal body

Diagnostic, examination, and monitoring equipment, namely, cantilever-based, immunoassays that enable direct detection of antigens, viruses, bacteria, DNA fragments, RNA fragments, proteins, oligonucleotides and other chemical species, all for medical purposes; medical and veterinary apparatus and instruments, namely, portable devices featuring diagnostic systems, for recording, displaying, receiving health and wellness related text, data and files, and including sensors for medical use to be worn by a human or animal to gather biometric data; diagnostic apparatus for medical purposes, namely, for detection of target molecules in body fluids or other specimen for diagnostics and detection of status; testing apparatus for medical purposes, namely, point-of-care testing devices for detecting antigens, proteins, biomolecules or proteins for determination of infections with viruses or bacteria, laboratory testing devices for detecting antigens, proteins, biomolecules or proteins for determination of infections with viruses or bacteria

Filing History

APPLICANT/CORRESPONDENCE CHANGES (NON-RESPONSIVE) ENTERED
Nov 18, 2022 CHAN
TEAS CHANGE OF CORRESPONDENCE RECEIVED
Nov 18, 2022 TCCA
TEAS CHANGE OF DOMESTIC REPRESENTATIVES ADDRESS
Nov 18, 2022 ECDR
ATTORNEY/DOM.REP.REVOKED AND/OR APPOINTED
Nov 18, 2022 ARAA
TEAS REVOKE/APP/CHANGE ADDR OF ATTY/DOM REP RECEIVED
Nov 18, 2022 REAP
TEAS CHANGE OF OWNER ADDRESS RECEIVED
Nov 18, 2022 COAR
REGISTERED-PRINCIPAL REGISTER
Dec 28, 2021 R.PR
OFFICIAL GAZETTE PUBLICATION CONFIRMATION E-MAILED
Oct 12, 2021 NPUB
PUBLISHED FOR OPPOSITION
Oct 12, 2021 PUBO
NOTIFICATION OF NOTICE OF PUBLICATION E-MAILED
Sep 22, 2021 NONP
EXPARTE APPEAL TERMINATED
Sep 3, 2021 EXPT
APPROVED FOR PUB - PRINCIPAL REGISTER
Sep 3, 2021 CNSA
TEAS/EMAIL CORRESPONDENCE ENTERED
Aug 30, 2021 TEME
CORRESPONDENCE RECEIVED IN LAW OFFICE
Aug 30, 2021 CRFA
ASSIGNED TO LIE
Aug 23, 2021 ALIE
EX PARTE APPEAL-INSTITUTED
Aug 17, 2021 EXPI
JURISDICTION RESTORED TO EXAMINING ATTORNEY
Aug 17, 2021 JURT
EXPARTE APPEAL RECEIVED AT TTAB
Aug 17, 2021 EXAF
TEAS REQUEST FOR RECONSIDERATION RECEIVED
Aug 16, 2021 ERFR
NOTIFICATION OF FINAL REFUSAL EMAILED
Feb 18, 2021 GNFN
FINAL REFUSAL E-MAILED
Feb 18, 2021 GNFR
FINAL REFUSAL WRITTEN
Feb 18, 2021 CNFR
TEAS/EMAIL CORRESPONDENCE ENTERED
Feb 12, 2021 TEME
CORRESPONDENCE RECEIVED IN LAW OFFICE
Feb 11, 2021 CRFA
TEAS RESPONSE TO OFFICE ACTION RECEIVED
Feb 11, 2021 TROA
TEAS CHANGE OF CORRESPONDENCE RECEIVED
Feb 5, 2021 TCCA
TEAS WITHDRAWAL OF ATTORNEY RECEIVED-FIRM RETAINS
Feb 5, 2021 EWAF
ATTORNEY/DOM.REP.REVOKED AND/OR APPOINTED
Feb 5, 2021 ARAA
TEAS REVOKE/APP/CHANGE ADDR OF ATTY/DOM REP RECEIVED
Feb 5, 2021 REAP
ATTORNEY REVIEW COMPLETED
Oct 8, 2020 ATRV
APPLICANT/CORRESPONDENCE CHANGES (NON-RESPONSIVE) ENTERED
Oct 7, 2020 CHAN
ASSIGNED TO LIE
Oct 6, 2020 ALIE
TEAS VOLUNTARY AMENDMENT RECEIVED
Aug 28, 2020 PARI
NOTIFICATION OF NON-FINAL ACTION E-MAILED
Aug 11, 2020 GNRN
NON-FINAL ACTION E-MAILED
Aug 11, 2020 GNRT
NON-FINAL ACTION WRITTEN
Aug 11, 2020 CNRT
ASSIGNED TO EXAMINER
Aug 11, 2020 DOCK
PETITION TO DIRECTOR GRANTED
Aug 7, 2020 PCGR
ASSIGNED TO PETITION STAFF
Aug 6, 2020 APET
TEAS PETITION TO DIRECTOR RECEIVED
Jul 28, 2020 TPDR
NEW APPLICATION OFFICE SUPPLIED DATA ENTERED
Jul 16, 2020 NWOS
NEW APPLICATION ENTERED
Jun 23, 2020 NWAP